World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
29938
World Ranking
11344
National Ranking
5822

Overview

Robert B. Dickson was affiliated with Georgetown University Medical Center in the United States. Their research spanned multiple areas within medicine and biochemistry, with a focus on pharmacology, endocrinology, diabetes and metabolism, biochemistry, molecular biology, and plant science.

Their published work included investigations into natural antidiabetic agents, phytochemicals, antioxidant activities, and studies on traditional and medicinal uses of plants, particularly within the Annonaceae family. The topics covered by their research were diverse and mainly centered on pharmacological effects of natural compounds, ethnobotanical and medicinal plants studies, and andrographolide research and applications.

Frequent coauthors in their research included Isaac Kingsley Amponsah, Edmund Ekuadzi, John Nii Addotey, Francis Ackah Armah, and Benjamin Kingsley Harley.

Most of Robert B. Dickson's research was published in several key venues, with multiple papers appearing in Scientific African, Natural Product Research, DARU Journal of Pharmaceutical Sciences, Biomedicine & Pharmacotherapy, and the Asian Pacific Journal of Tropical Biomedicine.

Some notable recent papers authored or coauthored by Robert B. Dickson include:

  • West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19, 2022, DARU Journal of Pharmaceutical Sciences
  • Flavanols and triterpenoids from Myrianthus arboreus ameliorate hyperglycaemia in streptozotocin-induced diabetic rats possibly via glucose uptake enhancement and α-amylase inhibition, 2020, Biomedicine & Pharmacotherapy
  • Antidiabetic effect of Chrysophyllum albidum is mediated by enzyme inhibition and enhancement of glucose uptake via 3T3-L1 adipocytes and C2C12 myotubes, 2020, Asian Pacific Journal of Tropical Biomedicine
  • In vitro antileishmanial activity and molecular docking studies of lupeol and monostearin, isolated from Parkia biglobosa, 2022, Scientific African
  • In vivo toxicity, anti-hyperlipidaemic, antioxidant and anti-atherogenic activities of 'LIPO A' A traditional herbal product in rodents, 2024, Heliyon

Best Publications

  • A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

    Richard M. Neve;Richard M. Neve;Koei Chin;Jane Fridlyand;Jennifer Yeh

  • Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

    Cornelius Knabbe;Marc E. Lippman;Lalage M. Wakefield;Kathleen C. Flanders

  • Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma

    Robert B. Dickson;Marc E. Lippman

  • Matrix metalloproteinase inhibitors

    Slawomir M. Wojtowicz-Praga;Robert B. Dickson;Michael J. Hawkins

  • Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.

    Erik W. Thompson;Soonmyoung Paik;Nils Brünner;Connie L. Sommers

  • Growth factors in breast cancer.

    Robert B. Dickson;Marc E. Lippman

  • Autocrine and paracrine growth regulation of human breast cancer

    Marc E. Lippman;Robert B. Dickson;Susan Bates;Cornelius Knabbe

  • Characterization of estrogen responsive transforming activity in human breast cancer cell lines

    Robert B. Dickson;Susan E. Bates;Mary E. McManaway;Marc E. Lippman

  • Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells

    K K Huff;D Kaufman;K H Gabbay;E M Spencer

  • Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

    Susan E. Bates;Nancy E. Davidson;Eva M. Valverius;Carl E. Freter

  • Induction of Epidermal Growth Factor-Related Polypeptides by 17β-Estradiol in MCF-7 Human Breast Cancer Cells

    R. B. Dickson;K. K. Huff;E. M. Spencer;Marc E. Lippman

  • Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth

    Robert B. Dickson;Mary E. McManaway;Marc E. Lippman

  • Epidermal Growth Factor Receptor Gene Expression in Estrogen Receptor-Positive and Negative Human Breast Cancer Cell Lines

    Nancy E. Davidson;Edward P. Gelmann;Marc E. Lippman;Robert B. Dickson

  • C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

    S L Deming;S J Nass;R B Dickson;B J Trock

  • Multicolour spectral karyotyping of mouse chromosomes.

    M Liyanage;A Coleman;S du Manoir;T Veldman

  • Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.

    D. A. Bronzert;P. Pantazis;H. N. Antoniades;A. Kasid

  • Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

    Jung Y. Kang;Marisa Dolled-Filhart;Idris Tolgay Ocal;Baljit Singh

  • Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk.

    Chen-Yong Lin;Joanna Anders;Michael Johnson;Robert B. Dickson

  • Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

    S Wojtowicz-Praga;J Torri;M Johnson;V Steen

  • Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity

    Chen-Yong Lin;Joanna Anders;Michael Johnson;Qingxiang Amy Sang

Frequent Co-Authors

Marc E. Lippman
Marc E. Lippman National Institutes of Health
Chen-Yong Lin
Chen-Yong Lin Georgetown University
Susan E. Bates
Susan E. Bates Columbia University
Mark C. Willingham
Mark C. Willingham Wake Forest University
Ira Pastan
Ira Pastan Center for Cancer Research
David S. Salomon
David S. Salomon National Institutes of Health
Glenn Merlino
Glenn Merlino National Institutes of Health
Erik W. Thompson
Erik W. Thompson Queensland University of Technology
Peter P. Roller
Peter P. Roller National Institutes of Health
Robert Clarke
Robert Clarke University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in medicine but want a flexible or alternative path, there are many online healthcare degrees and career pathways to consider. For those looking to enter the nursing field without extensive entrance exams, you can explore nursing school without TEAS test options, making nursing education more accessible.

If you aim for leadership roles, healthcare administration degree programs are available online and often offer accelerated formats. These programs prepare graduates for management and policy positions in hospitals, clinics, or healthcare organizations.

Registered nurses looking to advance their careers can enroll in RN to NP programs online, bridging the gap from an associate degree in nursing to a nurse practitioner role with greater responsibilities and increased earning potential.

Those passionate about diet, wellness, and preventative care should consider an online nutritionist degree, which equips students to work in hospitals, private practice, or community health.

Best Scientists Citing Robert B. Dickson

Recently Published Articles